These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35693801)

  • 1. Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis.
    Sasaki I; Kato T; Hemmi H; Fukuda-Ohta Y; Wakaki-Nishiyama N; Yamamoto A; Kaisho T
    Front Immunol; 2022; 13():857954. PubMed ID: 35693801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Cre-Expressing Mouse Strains Permitting to Selectively Track and Edit Type 1 Conventional Dendritic Cells Facilitate Disentangling Their Complexity
    Mattiuz R; Wohn C; Ghilas S; Ambrosini M; Alexandre YO; Sanchez C; Fries A; Vu Manh TP; Malissen B; Dalod M; Crozat K
    Front Immunol; 2018; 9():2805. PubMed ID: 30564233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1.
    Yamazaki C; Sugiyama M; Ohta T; Hemmi H; Hamada E; Sasaki I; Fukuda Y; Yano T; Nobuoka M; Hirashima T; Iizuka A; Sato K; Tanaka T; Hoshino K; Kaisho T
    J Immunol; 2013 Jun; 190(12):6071-82. PubMed ID: 23670193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial roles of XCR1-expressing dendritic cells and the XCR1-XCL1 chemokine axis in intestinal immune homeostasis.
    Ohta T; Sugiyama M; Hemmi H; Yamazaki C; Okura S; Sasaki I; Fukuda Y; Orimo T; Ishii KJ; Hoshino K; Ginhoux F; Kaisho T
    Sci Rep; 2016 Mar; 6():23505. PubMed ID: 27005831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
    Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
    Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Wylie B; Read J; Buzzai AC; Wagner T; Troy N; Syn G; Stone SR; Foley B; Bosco A; Cruickshank MN; Waithman J
    Front Immunol; 2018; 9():2990. PubMed ID: 30700986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
    Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.
    He F; Wu Z; Liu C; Zhu Y; Zhou Y; Tian E; Rosin-Arbesfeld R; Yang D; Wang MW; Zhu D
    Signal Transduct Target Ther; 2024 May; 9(1):139. PubMed ID: 38811552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1.
    Hartung E; Becker M; Bachem A; Reeg N; Jäkel A; Hutloff A; Weber H; Weise C; Giesecke C; Henn V; Gurka S; Anastassiadis K; Mages HW; Kroczek RA
    J Immunol; 2015 Feb; 194(3):1069-79. PubMed ID: 25520399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplored horizons of cDC1 in immunity and tolerance.
    Balan S; Radford KJ; Bhardwaj N
    Adv Immunol; 2020; 148():49-91. PubMed ID: 33190733
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Bagadia P; O'Connor KW; Wu R; Ferris ST; Ward JP; Schreiber RD; Murphy TL; Murphy KM
    J Immunol; 2021 Jul; 207(1):125-132. PubMed ID: 34135058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
    Swartz AM; Nair SK
    Curr Protoc; 2022 Apr; 2(4):e410. PubMed ID: 35435334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Halitzki E; Zahan T; Arh N; Zimmermannová O; Ferreira AG; Li H; Karlsson S; Scheding S; Pereira CF
    Sci Immunol; 2022 Mar; 7(69):eabg5539. PubMed ID: 35245086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors.
    Heger L; Hatscher L; Liang C; Lehmann CHK; Amon L; Lühr JJ; Kaszubowski T; Nzirorera R; Schaft N; Dörrie J; Irrgang P; Tenbusch M; Kunz M; Socher E; Autenrieth SE; Purbojo A; Sirbu H; Hartmann A; Alexiou C; Cesnjevar R; Dudziak D
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2300343120. PubMed ID: 37566635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
    Balan S; Dalod M
    Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cDC1 and cDC2 dendritic cells priming naive CD8
    Si Y; Wang Y; Tian Q; Wang Q; Pollard JM; Srivastava PK; Esser-Kahn AP; Collier JH; Sperling AI; Chong AS
    Cell Rep; 2023 Oct; 42(10):113299. PubMed ID: 37864794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XCR1
    Inui H; Nishida M; Ichii M; Nakaoka H; Asaji M; Ide S; Saito S; Saga A; Omatsu T; Tanaka K; Kanno K; Chang J; Zhu Y; Okada T; Okuzaki D; Matsui T; Ohama T; Koseki M; Morii E; Hosen N; Yamashita S; Sakata Y
    J Mol Cell Cardiol; 2023 Mar; 176():68-83. PubMed ID: 36739942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8
    Gardner A; de Mingo Pulido Á; Hänggi K; Bazargan S; Onimus A; Kasprzak A; Conejo-Garcia JR; Rejniak KA; Ruffell B
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34987021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells.
    Crozat K; Guiton R; Contreras V; Feuillet V; Dutertre CA; Ventre E; Vu Manh TP; Baranek T; Storset AK; Marvel J; Boudinot P; Hosmalin A; Schwartz-Cornil I; Dalod M
    J Exp Med; 2010 Jun; 207(6):1283-92. PubMed ID: 20479118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.